Cargando…

Co-insurance and health care utilization in Japanese patients with rheumatoid arthritis: a discontinuity regression approach

BACKGROUND: Co-insurance rates in Japan decrease when patients turn 70 years of age. We aim to compare changes in medical demand for Japanese patients with rheumatoid arthritis (RA) at age 70 prior to 2014, when there was a reduction in co-insurance rates from 30 to 10%, with changes in medical dema...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mahlich, Jörg, Sruamsiri, Rosarin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350300/ https://www.ncbi.nlm.nih.gov/pubmed/30691462 http://dx.doi.org/10.1186/s12939-019-0920-7

Ejemplares similares

The underrated prevalence of depression in Japanese patients with rheumatoid arthritis - evidence from a Nationwide survey in Japan
por: Sruamsiri, Rosarin, et al.
Publicado: (2017)

Persistence with biologic agents for the treatment of rheumatoid arthritis in Japan
por: Mahlich, Jörg, et al.
Publicado: (2016)

Shared Decision-Making and Patient Satisfaction in Japanese Rheumatoid Arthritis Patients: A New “Preference Fit” Framework for Treatment Assessment
por: Mahlich, Jörg, et al.
Publicado: (2019)

Hospitalization costs and length of stay of Japanese children with respiratory syncytial virus: A structural equation modeling approach
por: Sruamsiri, Rosarin, et al.
Publicado: (2018)

Biologic treatment of Japanese patients with inflammatory bowel disease
por: Mahlich, Jörg, et al.
Publicado: (2018)

Drug Utilization of Japanese Patients Diagnosed with Schizophrenia: An Administrative Database Analysis
por: Cheung, Stephane, et al.
Publicado: (2017)

Persistence with Biological Disease-modifying Antirheumatic Drugs and Its Associated Resource Utilization and Costs
por: Sruamsiri, Rosarin, et al.
Publicado: (2018)

Cultural beliefs, utility values, and health technology assessment
por: Mahlich, Jörg, et al.
Publicado: (2018)

Preferences Regarding Shared Decision-Making in Japanese Inflammatory Bowel Disease Patients
por: Morishige, Ryuji, et al.
Publicado: (2016)

Impact of patient characteristics and treatment procedures on hospitalization cost and length of stay in Japanese patients with influenza: A structural equation modelling approach
por: Sruamsiri, Rosarin, et al.
Publicado: (2017)

Persistence rates and medical costs of biological therapies for psoriasis treatment in Japan: a real-world data study using a claims database
por: Sruamsiri, Rosarin, et al.
Publicado: (2018)

Treatment patterns and healthcare resource utilization in palmoplantar pustulosis patients in Japan: A claims database study
por: Miyazaki, Celine, et al.
Publicado: (2020)

Impact of discontinuity in health insurance on resource utilization
por: Banerjee, Ritesh, et al.
Publicado: (2010)

Compliance and discontinuation of denosumab treatment in postmenopausal Japanese women with primary osteoporosis or rheumatoid arthritis and osteoporosis
por: Suzuki, Takako, et al.
Publicado: (2017)

The impact of retirement on inpatient healthcare utilization in Guangzhou, China: a regression discontinuity analysis of 189,031 health insurance claims
por: Zhao, Xintong, et al.
Publicado: (2022)

Cost utility analysis of reduced intensity hematopoietic stem cell transplantation in adolescence and young adult with severe thalassemia compared to hypertransfusion and iron chelation program
por: Sruamsiri, Rosarin, et al.
Publicado: (2013)

Quality of Reporting of Randomised Controlled Trials of Herbal Interventions in ASEAN Plus Six Countries: A Systematic Review
por: Pratoomsoot, Chayanin, et al.
Publicado: (2015)

The relationship between socio-demographic factors, health status, treatment type, and employment outcome in patients with inflammatory bowel disease in Japan
por: Mahlich, J, et al.
Publicado: (2017)

Full dose, reduced dose or discontinuation of etanercept in rheumatoid arthritis
por: van Vollenhoven, Ronald F, et al.
Publicado: (2016)

The Effect of Discontinuing Denosumab in Patients With Rheumatoid Arthritis Treated With Glucocorticoids
por: Saag, Kenneth G., et al.
Publicado: (2022)

Tapering and discontinuation of glucocorticoids in patients with rheumatoid arthritis treated with tofacitinib
por: Spinelli, Francesca Romana, et al.
Publicado: (2023)

Effects of inadequate coverage on healthcare utilization: A regression discontinuity analysis
por: Dugan, Jerome A., et al.
Publicado: (2021)

Validation of rheumatoid arthritis diagnoses in health care utilization data
por: Kim, Seo Young, et al.
Publicado: (2011)

Factors associated with successful discontinuation of certolizumab pegol in early rheumatoid arthritis
por: Tanaka, Yoshiya, et al.
Publicado: (2020)

Regression discontinuity threshold optimization
por: Marinescu, Ioana, et al.
Publicado: (2022)

Time to Treatment Discontinuation in German Patients with Schizophrenia: Long-Acting Injectables versus Oral Antipsychotics
por: Mahlich, Jörg, et al.
Publicado: (2020)

Cost-utility analysis of treatment options after initial tumor necrosis factor inhibitor therapy discontinuation in patients with rheumatoid arthritis
por: Karpes Matusevich, Aliza R, et al.
Publicado: (2021)

The Impact of the Eligibility Threshold of a French Means‐Tested Health Insurance Programme on Doctor Visits: A Regression Discontinuity Analysis
por: Guthmuller, Sophie, et al.
Publicado: (2017)

Pharmacoeconomic analysis of biologics and methotrexate for rheumatoid arthritis from the standpoint of the number needed to treat concept under the Japanese health insurance system
por: Harigane, Kengo, et al.
Publicado: (2022)

Acute anterior uveitis after discontinuation of tocilizumab in a patient with rheumatoid arthritis
por: Sato, Tomohito, et al.
Publicado: (2014)

Discontinuation of Biologic Therapy in Rheumatoid Arthritis: Analysis from the Corrona RA Registry
por: Strand, Vibeke, et al.
Publicado: (2017)

Adherence and rehospitalizations in patients with schizophrenia: evidence from Japanese claims data
por: Kuwabara, Hiroyo, et al.
Publicado: (2015)

The impact of vocational rehabilitation on employment outcomes: A regression discontinuity approach
por: Laaksonen, Mikko, et al.
Publicado: (2022)

Policies and Programs to Facilitate Access to Targeted Cancer Therapies in Thailand
por: Sruamsiri, Rosarin, et al.
Publicado: (2015)

Association Between the Extent of Periodontal Inflammation and the Severity of Rheumatoid Arthritis in Japanese Patients With Rheumatoid Arthritis
por: Hashimoto, Hiroko, et al.
Publicado: (2021)

Regression Discontinuity Designs in Health: A Systematic Review
por: Hilton Boon, Michele, et al.
Publicado: (2020)

Burden of rheumatoid arthritis among US Medicare population: co-morbidities, health-care resource utilization and costs
por: Chen, Chieh-I, et al.
Publicado: (2018)

Reasons for discontinuation of subcutaneous biologic therapy in the treatment of rheumatoid arthritis: a patient perspective
por: Bolge, Susan C, et al.
Publicado: (2015)

Comparison of Biologic Discontinuation in Patients With Elderly‐Onset Versus Younger‐Onset Rheumatoid Arthritis
por: Richter, Michael D., et al.
Publicado: (2019)

Using LASSO Regression to Predict Rheumatoid Arthritis Treatment Efficacy
por: Odgers, David J., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7hkcjd7vd8c4dvtaj88gv55coq